Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Combination therapy comprising nivolumab and ipilimumab

US Patent 11612654 · Granted Mar 28, 2023

Estimated economic value: $211,451,000

Assignee

Inventors

View full patent text on Google Patents →